IMVT: Immunovant, Inc. Company Short-Term Debt
Immunovant, Inc. (IMVT) attracts top biologists with ambitious antibody developments, while patents for bispecific compounds create a stringent barrier to entry for competitors. Short-term debt confirms the financial dynamics, where the indicator value is 0.00. High R&D expenditures and complex drug certification make this sector accessible only to companies with colossal capital.
Metric breakdowns and analytics for Immunovant Therapeutics (IMVT)
- current quotes and average value forecast:
- market capitalization information:
- shareholders' equity book value data:
- debt and liquidity data:
Total Debt to Capital Immunovant, Inc.|IMVT - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Immunovant, Inc.|IMVT - Company Total Debt|Debt to Book Capitalization Ratio Immunovant, Inc.|IMVT - Company Long-Term Liabilities|Company Current Liabilities Immunovant|Quick Liquidity immunovant.com
- net income and valuation multiples indicators:
Initial company analysis:IMVT - Immunovant
Short-term debt measures the total obligations maturing within one year, allowing for an assessment of current solvency and working capital management efficiency. By analyzing fluctuations in short-term debt, an investor can see how the financial stability of Immunovant, Inc. (IMVT) is maintained through steady inflows from the long-term autoimmune disease therapy cycle, which is protected by patent law.
Competitor analysis
ARGX - Company Short-Term Debt|Company Short-Term Loans and Borrowings BNTX (BioNTech Inc.)|Abivax (ABVX) - Company Short-Term Debt|Company Current Liabilities ADMA Corp|PTGX (Protagonist Therapeutics) - Company Short-Term Debts|Company Short-Term Debts kiniksa.com|Company Current Liabilities GRFS (Grifols)|ADPT (Adaptive Biotech) - Company Short-Term Loans and Borrowings|Company Short-Term Debts CLDX (Celldex)|Short-Term Debt Volume Aurinia Corp (AUPH)|BCRX - Company Short-Term Debt|veratx.com (VERA) - Company Current Liabilities|Dianthus Therapeutics, Inc. (DNTH) - Company Short-Term Debt|Company Current Liabilities Pharvaris NV|Company Current Liabilities ABCL|Company Short-Term Debts Tourmaline|Company Short-Term Debt Precigen, Inc. (PGEN)|pharming.com - Company Short-Term Indebtedness|Company Short-Term Debts NKTR (Nektar Therapeutics Inc.)|Upstream Bio, Inc. (UPB) - Short-Term Debt|Zenas Biopharma, Inc. - Company Short-Term Debts|Short-Term Debt Volume Immunome Bio IMNM|Gossamer Bio, Inc. (GOSS) - Company Short-Term Debt|Company Current Liabilities kalvista.com|Company Short-Term Debt Septerna|Company Current Liabilities Pieris Pharma (PVLA)|Company Current Liabilities SVRA (Savara Corp)|Company Short-Term Debts Rigel Corp (RIGL)|Company Short-Term Debt AnaptysBio, Inc. ANAB|ATXS: Company Short-Term Indebtedness|ENGN - Company Short-Term Debt|Short-Term Debt rapt.com|JBIO (aerovatetx.com) - Company Current Liabilities|ACRS (Aclaris Therapeutics, Inc) - Company Short-Term Debt|KYTX (Kyverna Therapeutics) - Company Short-Term Debts|Company Short-Term Debts tizianalifesciences.com|Company Short-Term Debt Cabaletta Bio (CABA)|Ventyx Biosciences Inc. - Company Short-Term Indebtedness|Theratechnologies Inc - Company Current Liabilities|Amount of Current Liabilities AVTX (Avalo Therapeutics Inc)|ELDN: Company Current Liabilities|Company Short-Term Loans and Borrowings AGEN (agenusbio.com)|CLYM: Company Short-Term Debts|ZURA - Short-Term Debt Volume|Company Short-Term Debt aTyr|Company Short-Term Indebtedness ADAG (Adagene Corp)|Company Short-Term Debts IMA|Company Current Liabilities shattucklabs.com STTK|Equillium - Company Current Liabilities|Short-Term Debt Volume Connect Biopharma Holdings (CNTB)|Immunic Inc - Company Short-Term Debts|Short-Term Debt Volume Atara Biotherapeutics ATRA|inflarx.de (IFRX) - Company Short-Term Debt|Company Current Liabilities x4pharma.com|Company Current Liabilities ACET|Company Short-Term Debt CELU|Company Current Liabilities INMB (INmune Bio Corp)|Amount of Current Liabilities BRNS|Company Short-Term Debt Kezar Life Sciences KZR|SABS (sabbiotherapeutics.com) - Current Liabilities|Akari Therapeutics Plc - Company Short-Term Debts|Company Short-Term Loans and Borrowings ENLV (Enlivex Therapeutics)|QTTB: Company Short-Term Debts|GeoVax Corp (GOVX) - Company Short-Term Debts|Company Short-Term Debt Edesa Biotech, Inc.|IBIO: Company Short-Term Loans and Borrowings|Company Short-Term Debt Carisma Therapeutics (CARM)|Company Current Liabilities XTL Biopharmaceuticals Ltd XTLB|Company Short-Term Debts BOLT (Bolt Biotherapeutics, Inc.)|Company Short-Term Debts HCW Biologics, Inc. HCWB|APVO: Company Current Liabilities|Company Short-Term Loans and Borrowings AIM (aimimmuno.com)|ADTX: Company Short-Term Debts|GRI - Short-Term Debt Volume|Company Short-Term Debt XORTX|Company Current Liabilities Vyome Therapeutics (HIND)|Company Short-Term Debt Revelation Biosciences (REVB)|Company Current Liabilities indaptusrx.com INDP|Scinai Immunotherapeutics Ltd. - Company Current Liabilities|Company Short-Term Debts CalciMedica Inc CALI|AFMD - Company Short-Term Debt|ALLK (Allakos Inc.) - Company Short-Term Indebtedness|HOOK: Company Short-Term Debts|Short-Term Debt IGM Biosciences (IGMS)|ITOS (iTeos Therapeutics, Inc.) - Company Short-Term Debts|Ocean Biomedical Inc (OCEA) - Short-Term Debt Volume|Company Short-Term Debt TC BioPharm (Holdings) PLC (TCBP)|Company Current Liabilities Third Harmonic Bio Inc THRD